Identification of genetic markers that predicts adverse effects of new melanoma therapies

Identification of genetic markers that predicts adverse effects of new melanoma therapies - Identification of genetic markers that predicts adverse effects of new melanoma therapies

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028523

Enrollment

100

Registered

2017-09-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant melanoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are treated with systemic therapies

Exclusion criteria

Exclusion criteria: Patients who are followed for less than 3 months after the initiation of the therapy

Design outcomes

Primary

Measure	Time frame
Adverse effect that result from new melanoma therapy	—

Countries

Japan

Contacts

Public ContactChisa Nakashima

Kyoto University Dermatology

chisa313@kuhp.kyoto-u.ac.jp075-751-33310

Outcome results